Literature DB >> 21059377

Silk fibroin as a vehicle for drug delivery applications.

Esther Wenk1, Hans P Merkle, Lorenz Meinel.   

Abstract

Silk fibroin (SF), a naturally occurring protein polymer, has several unique properties making it a favorable matrix for the incorporation and delivery of a range of therapeutic agents. SF is biocompatible, slowly biodegradable, and endowed with excellent mechanical properties and processability. Novel manufacturing techniques including mild all-aqueous processes have expanded its range of application even to sensitive protein and nucleic acid therapeutics. SF matrices were demonstrated to successfully deliver protein drugs and preserve their potency. Adjustments in SF crystallinity, concentration and structure, the design of the delivery systems as well as the molecular weight and structure of the embedded agents represent important variables when it comes to precisely tailor the release kinetics of SF matrices. Other strategies to fine-tune the release from SF matrices comprise the embedment of drug loaded micro- or nanoparticles or the coating of micro- or nanoparticles with SF films. So far, the main focus of SF drug delivery systems has been on tissue regeneration applications. For instance, growth factor loaded SF scaffolds were suggested for the tissue engineering of bone and cartilage, as well as for vascular and nerve regeneration devices and wound healing products. Moreover, SF matrices were proposed for oral, transmucosal and ocular drug delivery. This article reviews SF properties and fabrication processes that affect the release from SF drug delivery systems. For illustration, we discuss a variety of examples for the incorporation of drugs into SF systems and their release.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059377     DOI: 10.1016/j.jconrel.2010.11.007

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  84 in total

1.  Silk-Its Mysteries, How It Is Made, and How It Is Used.

Authors:  Davoud Ebrahimi; Olena Tokareva; Nae Gyune Rim; Joyce Y Wong; David L Kaplan; Markus J Buehler
Journal:  ACS Biomater Sci Eng       Date:  2015-08-24

Review 2.  Review physical and chemical aspects of stabilization of compounds in silk.

Authors:  Eleanor M Pritchard; Patrick B Dennis; Fiorenzo Omenetto; Rajesh R Naik; David L Kaplan
Journal:  Biopolymers       Date:  2012-01-23       Impact factor: 2.505

Review 3.  Extended release formulations using silk proteins for controlled delivery of therapeutics.

Authors:  Burcin Yavuz; Laura Chambre; David L Kaplan
Journal:  Expert Opin Drug Deliv       Date:  2019-07-01       Impact factor: 6.648

4.  Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination.

Authors:  Archana V Boopathy; Anasuya Mandal; Daniel W Kulp; Sergey Menis; Nitasha R Bennett; Hannah C Watkins; Wade Wang; Jacob T Martin; Nikki T Thai; Yanpu He; William R Schief; Paula T Hammond; Darrell J Irvine
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

5.  A quicker degradation rate is yielded by a novel kind of transgenic silk fibroin consisting of shortened silk fibroin heavy chains fused with matrix metalloproteinase cleavage sites.

Authors:  Guoping Huang; Danfeng Yang; Chunfeng Sun; Jianping Huang; Keping Chen; Chunxia Zhang; Huiqing Chen; Qin Yao
Journal:  J Mater Sci Mater Med       Date:  2014-05-07       Impact factor: 3.896

6.  Biopolymers and supramolecular polymers as biomaterials for biomedical applications.

Authors:  Ronit Freeman; Job Boekhoven; Matthew B Dickerson; Rajesh R Naik; Samuel I Stupp
Journal:  MRS Bull       Date:  2015-11-01       Impact factor: 6.578

7.  Multifunctional silk-heparin biomaterials for vascular tissue engineering applications.

Authors:  F Philipp Seib; Manuela Herklotz; Kelly A Burke; Manfred F Maitz; Carsten Werner; David L Kaplan
Journal:  Biomaterials       Date:  2013-10-04       Impact factor: 12.479

8.  Antibiotic-Releasing Silk Biomaterials for Infection Prevention and Treatment.

Authors:  Eleanor M Pritchard; Thomas Valentin; Bruce Panilaitis; Fiorenzo Omenetto; David L Kaplan
Journal:  Adv Funct Mater       Date:  2012-09-26       Impact factor: 18.808

9.  Effect of silk protein processing on drug delivery from silk films.

Authors:  Eleanor M Pritchard; Xiao Hu; Violet Finley; Catherine K Kuo; David L Kaplan
Journal:  Macromol Biosci       Date:  2013-01-24       Impact factor: 4.979

Review 10.  Silk-based biomaterials for sustained drug delivery.

Authors:  Tuna Yucel; Michael L Lovett; David L Kaplan
Journal:  J Control Release       Date:  2014-06-05       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.